AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Strata Skin (SSKN) reported Q3 revenue of $6.9 million, down 20% YoY, due to international market challenges. Gross profit was $4.2 million, with a 60% gross margin, flat from the prior year. Global recurring revenue increased 3% YoY, while equipment revenue declined 60% YoY. Net loss was $1.6 million, or $0.36 per share, and cash and equivalents stood at $7.1 million. The company raised $2.2 million through a registered direct offering and expanded CPT codes for the XTRAC excimer laser, potentially tripling the addressable patient population.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet